⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NERV News
Minerva Neurosciences, Inc
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates
globenewswire.com
NERV
Minerva Neurosciences to Participate in The Citizens Life Sciences Conference
globenewswire.com
NERV
Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality – Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026
globenewswire.com
NERV
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
globenewswire.com
NERV
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
globenewswire.com
NERV